Monitoring the Efficacy of Antiretroviral Therapy by a Simple Reverse Transcriptase Assay in HIV-Infected Adults in Rural Vietnam

• Greengrass VL , PlateMM, SteelePM et al. Evaluation of the Cavidi ExaVir Load Assay (Version 3) for plasma human immunodeficiency virus type 1 load monitoring. J. Clin. Microbiol. 47(9) , 3011–3013 (2009).
   PubMed Web of Science ®Google Scholar
• Mine M , BediK, MarutaT et al. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. J. Virol. Methods 159(1) , 93–97 (2009).
   PubMed Web of Science ®Google Scholar
• Stevens WS , ScottLM, CroweSM. Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings. J. Infec. Dis. (Suppl. 1) , S16–S26 (2010).
   PubMed Web of Science ®Google Scholar
• Huang D , ZhuangY, ZhaiS et al. HIV reverse transcriptase activity assay: a feasible surrogate for HIV viral load measurement in China. Diagn. Microbiol. Infect. Dis. 68(3) , 208–213 (2010).
   PubMed Web of Science ®Google Scholar
• Iqbal HS , BalakrishnanP, CeceliaAJ et al. Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings. J. Med. Microbiol. 56(12) , 1611–1614 (2007).
   PubMed Web of Science ®Google Scholar
• Labbett W , Garcia-DiazA, FoxZ et al. Comparative evaluation of the ExaVir Load Version 3 reverse transcriptase assay for measurement of human immunodeficiency virus type 1 plasma load. J. Clin. Microbiol. 47(10) , 3266–3270 (2009).
   PubMed Web of Science ®Google Scholar
• Royston P , ParmarMK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat. Med.21(15) , 2175–2197 (2002).
   PubMed Web of Science ®Google Scholar
• Lambert PC , RoystonP. Further development of flexible parametric models for survival analysis. Stata. J.9(2) , 265–290 (2009)
   Web of Science ®Google Scholar
• Damond FA , CollinG, RoquebertB et al. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J. Clin. Virol. 48(4) , 1413–1416 (2010).
   Google Scholar
• Jordan MR , LaH, NguyenHD et al. Correlates of HIV-1 viral suppression in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam. Int. J. STD AIDS 20(6) , 418–422 (2009).
   PubMed Web of Science ®Google Scholar
• Trinh TT , MontagueBT, FlaniganTP, GerardHM. HIV suppression among patients on treatment in Vietnam: a review of HIV viral load testing in a public urban clinic in Ho Chi Minh City. AIDS Res. Treat.2011 , 230953 (2011).
   PubMedGoogle Scholar
• Huong DTM , BannisterW, PhongPT, KirkO, PetersL. Factors associated with HIV-1 virological failure in an outpatient clinic for HIV-infected people in Haiphong, Vietnam. Int. J. STD AIDS22(11) , 659–664 (2011).
   PubMed Web of Science ®Google Scholar
• Ferradini L , LaureillardD, PrakN et al. Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS 21(17) , 2293–2301 (2007).
   PubMed Web of Science ®Google Scholar
• Tsuchiya N PP, Yasuda T, Mukoyama Y et al. Demographic, socio-economic, behavioral and clinical factors predicting virologic failure with generic fixed-dose combination antiretroviral therapy before universal health insurance coverage in northern Thailand. Southeast Asian J. Trop. Med. Public Health40(1) , 71–82 (2009).
   PubMed Web of Science ®Google Scholar
• Ma Y , ZhaoD, YuL et al. Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China. Clin. Infect. Dis. 50(2) , 264–271 (2009).
   Web of Science ®Google Scholar
• Nettles RE , KiefferTL, KwonP et al. Intermittent HIV-1 viremia (blips) and drug resistance in patients receiving HAART. JAMA 293(7) , 817–829 (2005).
   PubMed Web of Science ®Google Scholar
• Cuong DD , ThorsonA, SönnerborgA et al. Survival and causes of death among HIV-infected patients starting antiretroviral therapy in north-eastern Vietnam. Scand. J. Infec. Dis. 44(3) , 201–208 (2012).
   PubMed Web of Science ®Google Scholar
• Lawn S , HarriesA, AnglaretX, MyerL, WoodR. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS22 , 1897–1908 (2008).
   PubMed Web of Science ®Google Scholar
• Gill J , MayM, LewdenC et al. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies. Clin. Infect. Dis. 50(10) , 1387–1396 (2010).
   PubMed Web of Science ®Google Scholar
• Brinkhof MW , DabisF, MyerL et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull. World Health Organ. 86(7) , 559–567 (2008).
   PubMed Web of Science ®Google Scholar
• Ugbena R , Aberle-GrasseJ, DialloK et al. Virological response and HIV drug resistance 12 months after antiretroviral therapy initiation at 2 clinics in Nigeria. Clin. Infect. Dis. 54(Suppl. 4) , S375–S380 (2008).
   Google Scholar
• Brinkhof MWG , Pujades-RodriguezM, EggerM. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One4(6) , e5790 (2009).
   PubMed Web of Science ®Google Scholar
• Calmy A , FordN, HirschelB et al. HIV viral load monitoring in resource-limited regions: optional or necessary? Clin. Infect. Dis. 44(1) , 128–134 (2007).
   PubMed Web of Science ®Google Scholar
• Napravnik S , CachafeiroA, StewartP, EronJJ, FiscusSA. HIV-1 viral load and phenotypic antiretroviral drug resistance assays based on reverse transcriptase activity in comparison to amplification based HIV-1 RNA and genotypic assays. J. Clin. Virol.47(1) , 18–22 (2010).
   PubMed Web of Science ®Google Scholar
• Sivapalasingam S , WangechiB, MarshedF et al. Monitoring virologic responses to antiretroviral therapy in HIV-infected adults in Kenya: evaluation of a low-cost viral load assay. PLoS One 4(8) , e6828 (2009).
   PubMed Web of Science ®Google Scholar
• Aboubakar Y , VenusY, OusmaneS et al. SMARThivVLmos: a complexity-free and cost effective dynamic model technology for monitoring HIV viral load in resource-poor settings. Bioinformation 2(6) , 246–248 (2008).
   PubMedGoogle Scholar
• Bendavid E , YoungSD, KatzensteinDA, BayoumiAM, SandersGD, OwensDK. Cost–effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysis. Arch. Intern. Med.168(17) , 1910–1918 (2008).
   PubMedGoogle Scholar
• Vijayaraghavan AEM , MazonsonPD, EbrahimO, SanneIM, SantasCC. Cost–effectiveness of alternative strategies for initiating and monitoring highly active antiretroviral therapy in the developing world. J. Acquir. Immune Defic. Syndr.1(46) , 91–100 (2007).
   Google Scholar
• Liao CH , ChenMY, HsiehSM, ShengWH, HungCC, ChangSC. Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection. J. Microbiol. Immunol. Infect.37(1) , 50–56 (2004).
   PubMedGoogle Scholar

Websites

• UNAIDS. Vietnam HIV/AIDS Estimates and Projections 2007–2012. www.unaids.org.vn/images/stories/EPP%20report%20EN.pdf
   Google Scholar
• MOH. Vietnam National Guidelines for HIV/AIDS diagnosis and treatment (this document is in Vietnamese, published with the Decision No. 06/2005/QD-BYT dated 07/03/2005 of the Minister of Health). www.vaac.gov.vn/Desktop.aspx/Van-ban-phap-quy/Bo-Y-te/4F5869C03E0E494689828A284C950ECE
   Google Scholar
• MoH. Vietnam National Guidelines for HIV/AIDS diagnosis and treatment (this document is in Vietnamese, published with the Decision No. 3003/QD-BYT dated 19/08/2009 of the Minister of Health). www.vaac.gov.vn/Desktop.aspx/Van-ban-phap-quy/Bo-Y-te/D00122AC0E644D888FD81DF9DA6C55F2
   Google Scholar
• WHO. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report. www.who.int/hiv/pub/2010progressreport/en
   Google Scholar
• WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach – 2010 rev. WHO Library Cataloguing-in-publication Data. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf
   Google Scholar
• CAVIDI. Instruction for use of ExaVir™ Load Analyzer Version 3.0, issued revised Mar 2009. www.cavidi.se/Templates/Cavidi/FileService.axd?id=412&v=1
   Google Scholar